Temporal brain microRNA expression changes in a mouse model of neonatal hypoxic-ischemic injury

Eric S Peeples1, Namood-E Sahar2, William Snyder2

  • 1Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA. epeeples@childrensomaha.org.

Pediatric Research
|September 1, 2021
PubMed
Abstract

Insights

Neonatal hypoxic-ischemic brain injury (HIBI) alters brain microRNA (miRNA) expression. Specific miRNAs like Mir-2137, -335, -137, and -376c show significant changes, offering potential therapeutic targets for HIBI.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Neonatal hypoxic-ischemic brain injury (HIBI) is a major cause of infant mortality and morbidity.
  • Current therapies for HIBI are limited, highlighting the need for novel therapeutic strategies.
  • MicroRNAs (miRNAs) are implicated in HIBI, but their expression patterns during the subacute phase (6-72 hours post-injury) are not well understood.

Purpose of the Study:

  • To comprehensively define endogenous brain miRNA expression changes in the subacute phase following neonatal HIBI.
  • To identify specific miRNAs that are differentially expressed after HIBI and could serve as therapeutic targets.
  • To investigate the temporal dynamics of miRNA expression changes in response to HIBI.

Main Methods:

  • Neonatal mouse pups (postnatal day 9) were subjected to unilateral carotid ligation and hypoxia (HIBI), sham surgery with hypoxia, or sham surgery with normoxia (controls).
  • miRNA sequencing was performed on ipsilateral and contralateral brain tissues at 24 and 72 hours post-injury.
  • Quantitative polymerase chain reaction (qPCR) was used to validate the expression levels of key differentially expressed miRNAs.

Main Results:

  • Significant differential expression of 38 miRNAs was observed at both 24 and 72 hours after HIBI.
  • Mir-2137, -335, -137, and -376c were significantly altered by neonatal HIBI at both time points.
  • Three of these four miRNAs exhibited multiphasic expression patterns, with differential expression in opposite directions at 24 versus 72 hours post-injury.

Conclusions:

  • This study provides the first comprehensive analysis of subacute brain miRNA expression changes following neonatal HIBI.
  • The identified miRNAs (Mir-2137, -335, -137, and -376c) represent promising candidates for targeted miRNA-based therapeutic interventions.
  • Understanding the multiphasic nature of miRNA expression is crucial for optimizing the timing of future HIBI interventions.

Related Concept Videos